Salt Lake City, UT, Aug. 18, 2017 -- SALT LAKE CITY, August 21, 2017 /PRNewswire/--ARUP Laboratories and IllumiCare have announced a strategic collaboration to provide clinicians with content and decision support.
|
|||||
In an era of rising patient deductibles and health insurance premiums, it is ever more important to spend healthcare dollars efficiently. Physicians are being asked to provide “value-based care,” yet they are not routinely told what things cost.
“ARUP has long been an advocate of empowering clinicians with current testing knowledge and providing unparalleled guidance through ARUP’s utilization management services,” says Andrew Fletcher, MD, the ARUP medical director of Consultative Services. “We are excited to share the research and expertise of our 90+ medical directors.”
IllumiCare’s Smart Ribbon is a non-intrusive ribbon of information that hovers over or embeds within the electronic medical record and provides real-time visibility of the cumulative risk and financial impact of tests and medications being ordered during the course of care. Studies show that displaying cost and risk of patient harm at the point of care causes physicians to provide safer and more efficient care.
“This partnership allows us to bring the expertise and best practice recommendations of a leading national reference laboratory to physicians at the point of care,” says G.T. LaBorde, CEO of IllumiCare. “Clinicians are being asked to remove waste and provide better care at a lower cost. The Smart Ribbon, with ARUP, provides valuable content for informed decision making, helping to reduce clinical and cost variation during the treatment of care.”
IllumiCare and ARUP together recognize that behind each lab test is a patient that may experience discomfort and a risk of harm. This collaboration seeks to ensure that patients receive the right test at the right time.
Media Contacts:
Cyndee Holden, (801) 583-2787, ext. 3318, [email protected]
G.T. LaBorde, (205) 719-8595, [email protected]
About ARUP Laboratories
Founded in 1984, ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a worldwide leader in innovative laboratory research and development. A nonprofit enterprise of the University of Utah, ARUP offers an extensive test menu of highly complex and unique medical tests ranging from routine screening tests to esoteric molecular and genetic assays. ARUP serves clients across the United States, including many of the nation's top university teaching hospitals and children's hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. ARUP is ISO 15189 CAP accredited.
About IllumiCare
Founded in 2014, IllumiCare displays clinical, financial, and patient safety data in a non-intrusive, EMR agnostic “ribbon.” The data displayed can be customized by facility, care setting, user type, and patient type. Cost transparency, predictive analytics, population health and other analytics are powerful tools. They are most effective when provided to your clinicians in real-time, at the point of care.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/86603cd9-a1e7-4efb-8ae8-27579dc70b74
Catherine Arnold ARUP Laboratories (801) 583-2787, ext. 3635 [email protected]


Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 



